BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1694698)

  • 1. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
    Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
    Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
    Takeuchi H; Katayama I
    Leuk Lymphoma; 1993 Jun; 10(3):209-16. PubMed ID: 8220119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
    Aljurf M; Cornbleet PJ; Michel F
    Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
    DiGiuseppe JA; Borowitz MJ
    Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
    Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
    Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
    Robak T
    Leuk Lymphoma; 2004 Feb; 45(2):205-19. PubMed ID: 15101704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
    Takeuchi H; Amano Y; Katayama I
    Leuk Lymphoma; 1994; 14 Suppl 1():49-56. PubMed ID: 7820053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density.
    D'Arena G; Dell'Olio M; Musto P; Cascavilla N; Perla G; Savino L; Greco MM
    Leuk Lymphoma; 2001 Aug; 42(4):649-54. PubMed ID: 11697493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+, CD11c+, CD20+ hairy cell leukemia.
    Heimann PS; Vardiman JW; Stock W; Platanias LC; Golomb HM
    Blood; 1991 Apr; 77(7):1617-9. PubMed ID: 1706957
    [No Abstract]   [Full Text] [Related]  

  • 17. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
    Kroft SH; Dawson DB; McKenna RW
    Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.